{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:11:11Z","timestamp":1791231071205,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T00:00:00Z","timestamp":1673827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T00:00:00Z","timestamp":1673827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA045726"],"award-info":[{"award-number":["R01CA045726"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R35CA220512"],"award-info":[{"award-number":["R35CA220512"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Cell Biol"],"DOI":"10.1038\/s41556-022-01055-y","type":"journal-article","created":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T17:03:08Z","timestamp":1673888588000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Pancreatic cancer cells upregulate LPAR4 in response to isolation stress to promote an ECM-enriched niche and support tumour initiation"],"prefix":"10.1038","author":[{"given":"Chengsheng","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taha","family":"Rakhshandehroo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7144-3122","authenticated-orcid":false,"given":"Hiromi I.","family":"Wettersten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tami","family":"von Schalscha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shashi","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4952-8899","authenticated-orcid":false,"given":"Ziqi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7010-5268","authenticated-orcid":false,"given":"Jiali","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangeline","family":"Mose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betzaira G.","family":"Childers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Lowy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara M.","family":"Weis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Cheresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,16]]},"reference":[{"key":"1055_CR1","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1056\/NEJMra1804280","volume":"380","author":"MF Clarke","year":"2019","unstructured":"Clarke, M. F. Clinical and therapeutic implications of cancer stem cells. N. Engl. J. Med. 380, 2237\u20132245 (2019).","journal-title":"N. Engl. J. Med."},{"key":"1055_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-017-0624-9","volume":"16","author":"P Zhou","year":"2017","unstructured":"Zhou, P. et al. The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer. Mol. Cancer 16, 52 (2017).","journal-title":"Mol. Cancer"},{"key":"1055_CR3","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.stem.2015.02.015","volume":"16","author":"V Plaks","year":"2015","unstructured":"Plaks, V., Kong, N. & Werb, Z. The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells? Cell Stem Cell 16, 225\u2013238 (2015).","journal-title":"Cell Stem Cell"},{"key":"1055_CR4","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.cell.2011.08.017","volume":"146","author":"JE Delmore","year":"2011","unstructured":"Delmore, J. E. et al. BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell 146, 904\u2013917 (2011).","journal-title":"Cell"},{"key":"1055_CR5","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1177\/15353702211019283","volume":"246","author":"G Tigyi","year":"2021","unstructured":"Tigyi, G., Lin, K. H., Jang, I. H. & Lee, S. C. Revisiting the role of lysophosphatidic acid in stem cell biology. Exp. Biol. Med. 246, 1802\u20131809 (2021).","journal-title":"Exp. Biol. Med."},{"key":"1055_CR6","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/stem.2279","volume":"34","author":"EJ Seo","year":"2016","unstructured":"Seo, E. J. et al. Autotaxin regulates maintenance of ovarian cancer stem cells through lysophosphatidic acid-mediated autocrine mechanism. Stem Cells 34, 551\u2013564 (2016).","journal-title":"Stem Cells"},{"key":"1055_CR7","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1097\/JCMA.0000000000000186","volume":"82","author":"KF Hung","year":"2019","unstructured":"Hung, K. F., Yang, T. & Kao, S. Y. Cancer stem cell theory: are we moving past the mist? J. Chin. Med. Assoc. 82, 814\u2013818 (2019).","journal-title":"J. Chin. Med. Assoc."},{"key":"1055_CR8","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.trecan.2016.06.004","volume":"2","author":"D Senft","year":"2016","unstructured":"Senft, D. & Ronai, Z. E. Adaptive stress responses during tumor metastasis and dormancy. Trends Cancer 2, 429\u2013442 (2016).","journal-title":"Trends Cancer"},{"key":"1055_CR9","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ccell.2020.06.001","volume":"38","author":"JD Hayes","year":"2020","unstructured":"Hayes, J. D., Dinkova-Kostova, A. T. & Tew, K. D. Oxidative stress in cancer. Cancer Cell 38, 167\u2013197 (2020).","journal-title":"Cancer Cell"},{"key":"1055_CR10","doi-asserted-by":"publisher","first-page":"102655","DOI":"10.1016\/j.ebiom.2020.102655","volume":"53","author":"W Yao","year":"2020","unstructured":"Yao, W., Maitra, A. & Ying, H. Recent insights into the biology of pancreatic cancer. EBioMedicine 53, 102655 (2020).","journal-title":"EBioMedicine"},{"key":"1055_CR11","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12876-021-01635-6","volume":"21","author":"J Chen","year":"2021","unstructured":"Chen, J., Li, H., Xu, W. & Guo, X. Evaluation of serum ATX and LPA as potential diagnostic biomarkers in patients with pancreatic cancer. BMC Gastroenterol. 21, 58 (2021).","journal-title":"BMC Gastroenterol."},{"key":"1055_CR12","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1158\/2159-8290.CD-18-1212","volume":"9","author":"FR Auciello","year":"2019","unstructured":"Auciello, F. R. et al. A stromal lysolipid-autotaxin signaling axis promotes pancreatic tumor progression. Cancer Discov. 9, 617\u2013627 (2019).","journal-title":"Cancer Discov."},{"key":"1055_CR13","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.devcel.2019.09.018","volume":"51","author":"A Juin","year":"2019","unstructured":"Juin, A. et al. N-WASP Control of LPAR1 Trafficking Establishes Response to Self-Generated LPA Gradients to Promote Pancreatic Cancer Cell Metastasis. Dev. Cell 51, 431\u2013445.e7 (2019).","journal-title":"Dev. Cell"},{"key":"1055_CR14","doi-asserted-by":"publisher","first-page":"6595","DOI":"10.1074\/jbc.M308133200","volume":"279","author":"T Yamada","year":"2004","unstructured":"Yamada, T. et al. Lysophosphatidic acid (LPA) in malignant ascites stimulates motility of human pancreatic cancer cells through LPA1. J. Biol. Chem. 279, 6595\u20136605 (2004).","journal-title":"J. Biol. Chem."},{"key":"1055_CR15","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1093\/carcin\/bgp011","volume":"30","author":"M Komachi","year":"2009","unstructured":"Komachi, M. et al. LPA1 receptors mediate stimulation, whereas LPA2 receptors mediate inhibition, of migration of pancreatic cancer cells in response to lysophosphatidic acid and malignant ascites. Carcinogenesis 30, 457\u2013465 (2009).","journal-title":"Carcinogenesis"},{"key":"1055_CR16","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.bbrc.2015.03.169","volume":"461","author":"S Ishii","year":"2015","unstructured":"Ishii, S. et al. Diverse effects of LPA4, LPA5 and LPA6 on the activation of tumor progression in pancreatic cancer cells. Biochem. Biophys. Res. Commun. 461, 59\u201364 (2015).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1055_CR17","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.ymthe.2020.11.004","volume":"29","author":"JW Lee","year":"2021","unstructured":"Lee, J. W. et al. Lysophosphatidic acid receptor 4 is transiently expressed during cardiac differentiation and critical for repair of the damaged heart. Mol. Ther. 29, 1151\u20131163 (2021).","journal-title":"Mol. Ther."},{"key":"1055_CR18","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.3390\/ijms22052622","volume":"22","author":"A Bartha","year":"2021","unstructured":"Bartha, A. & Gyorffy, B. TNMplot.com: a web tool for the comparison of gene expression in normal, tumor and metastatic tissues. Int. J. Mol. Sci. 22, 2622 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"1055_CR19","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1016\/j.ajpath.2015.04.001","volume":"185","author":"CK Sen","year":"2015","unstructured":"Sen, C. K. & Ghatak, S. miRNA control of tissue repair and regeneration. Am. J. Pathol. 185, 2629\u20132640 (2015).","journal-title":"Am. J. Pathol."},{"key":"1055_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2017.05.007","volume":"402","author":"AK Chaudhary","year":"2017","unstructured":"Chaudhary, A. K., Mondal, G., Kumar, V., Kattel, K. & Mahato, R. I. Chemosensitization and inhibition of pancreatic cancer stem cell proliferation by overexpression of microRNA-205. Cancer Lett. 402, 1\u20138 (2017).","journal-title":"Cancer Lett."},{"key":"1055_CR21","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/cells9010008","volume":"9","author":"X Jiao","year":"2019","unstructured":"Jiao, X. et al. microRNA: the impact on cancer stemness and therapeutic resistance. Cells 9, 8 (2019).","journal-title":"Cells"},{"key":"1055_CR22","first-page":"868","volume":"41","author":"J Ma","year":"2018","unstructured":"Ma, J., Zhang, J., Weng, Y. C. & Wang, J. C. EZH2-mediated microRNA-139-5p regulates epithelial\u2013mesenchymal transition and lymph node metastasis of pancreatic cancer. Mol. Cells 41, 868\u2013880 (2018).","journal-title":"Mol. Cells"},{"key":"1055_CR23","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/j.bbrc.2009.10.135","volume":"390","author":"LK Hasseine","year":"2009","unstructured":"Hasseine, L. K. et al. miR-139 impacts FoxO1 action by decreasing FoxO1 protein in mouse hepatocytes. Biochem. Biophys. Res. Commun. 390, 1278\u20131282 (2009).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1055_CR24","doi-asserted-by":"publisher","first-page":"697604","DOI":"10.3389\/fimmu.2021.697604","volume":"12","author":"I Okoye","year":"2021","unstructured":"Okoye, I. et al. Plasma extracellular vesicles enhance HIV-1 infection of activated CD4+ T cells and promote the activation of latently infected J-Lat10.6 cells via miR-139-5p transfer. Front. Immunol. 12, 697604 (2021).","journal-title":"Front. Immunol."},{"key":"1055_CR25","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.canlet.2015.12.027","volume":"381","author":"M Topalovski","year":"2016","unstructured":"Topalovski, M. & Brekken, R. A. Matrix control of pancreatic cancer: new insights into fibronectin signaling. Cancer Lett. 381, 252\u2013258 (2016).","journal-title":"Cancer Lett."},{"key":"1055_CR26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.cmet.2013.06.011","volume":"18","author":"MA Magnuson","year":"2013","unstructured":"Magnuson, M. A. & Osipovich, A. B. Pancreas-specific Cre driver lines and considerations for their prudent use. Cell Metab. 18, 9\u201320 (2013).","journal-title":"Cell Metab."},{"key":"1055_CR27","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41392-020-00367-5","volume":"6","author":"LHM Geraldo","year":"2021","unstructured":"Geraldo, L. H. M. et al. Role of lysophosphatidic acid and its receptors in health and disease: novel therapeutic strategies. Signal Transduct. Target Ther. 6, 45 (2021).","journal-title":"Signal Transduct. Target Ther."},{"key":"1055_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18794-x","volume":"11","author":"J Winkler","year":"2020","unstructured":"Winkler, J., Abisoye-Ogunniyan, A., Metcalf, K. J. & Werb, Z. Concepts of extracellular matrix remodelling in tumour progression and metastasis. Nat. Commun. 11, 5120 (2020).","journal-title":"Nat. Commun."},{"key":"1055_CR29","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.scr.2013.05.009","volume":"11","author":"J Ou","year":"2013","unstructured":"Ou, J. et al. Fibronectin extra domain A (EDA) sustains CD133+\/CD44+ subpopulation of colorectal cancer cells. Stem Cell Res. 11, 820\u2013833 (2013).","journal-title":"Stem Cell Res."},{"key":"1055_CR30","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3389\/fnmol.2018.00130","volume":"11","author":"Q Yu","year":"2018","unstructured":"Yu, Q. et al. Fibronectin promotes the malignancy of glioma stem-like cells via modulation of cell adhesion, differentiation, proliferation and chemoresistance. Front. Mol. Neurosci. 11, 130 (2018).","journal-title":"Front. Mol. Neurosci."},{"key":"1055_CR31","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.7150\/thno.50613","volume":"11","author":"C Zhong","year":"2021","unstructured":"Zhong, C. et al. Remodeling cancer stemness by collagen\/fibronectin via the AKT and CDC42 signaling pathway crosstalk in glioma. Theranostics 11, 1991\u20132005 (2021).","journal-title":"Theranostics"},{"key":"1055_CR32","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3389\/fonc.2020.00641","volume":"10","author":"G Efthymiou","year":"2020","unstructured":"Efthymiou, G. et al. Shaping up the tumor microenvironment with cellular fibronectin. Front. Oncol. 10, 641 (2020).","journal-title":"Front. Oncol."},{"key":"1055_CR33","doi-asserted-by":"publisher","first-page":"22584","DOI":"10.1074\/jbc.M112.421636","volume":"288","author":"K Nakayama","year":"2013","unstructured":"Nakayama, K. cAMP-response element-binding protein (CREB) and NF-kappaB transcription factors are activated during prolonged hypoxia and cooperatively regulate the induction of matrix metalloproteinase MMP1. J. Biol. Chem. 288, 22584\u201322595 (2013).","journal-title":"J. Biol. Chem."},{"key":"1055_CR34","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1080\/15384101.2015.1064204","volume":"14","author":"SL Habib","year":"2015","unstructured":"Habib, S. L., Mohan, S., Liang, S., Li, B. & Yadav, M. Novel mechanism of transcriptional regulation of cell matrix protein through CREB. Cell Cycle 14, 2598\u20132608 (2015).","journal-title":"Cell Cycle"},{"key":"1055_CR35","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1158\/1078-0432.CCR-08-1137","volume":"15","author":"KM Sakamoto","year":"2009","unstructured":"Sakamoto, K. M. & Frank, D. A. CREB in the pathophysiology of cancer: implications for targeting transcription factors for cancer therapy. Clin. Cancer Res. 15, 2583\u20132587 (2009).","journal-title":"Clin. Cancer Res."},{"key":"1055_CR36","first-page":"3703","volume":"125","author":"P Singh","year":"2012","unstructured":"Singh, P. & Schwarzbauer, J. E. Fibronectin and stem cell differentiation\u2014lessons from chondrogenesis. J. Cell Sci. 125, 3703\u20133712 (2012).","journal-title":"J. Cell Sci."},{"key":"1055_CR37","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1016\/j.bbagen.2014.01.010","volume":"1840","author":"F Gattazzo","year":"2014","unstructured":"Gattazzo, F., Urciuolo, A. & Bonaldo, P. Extracellular matrix: a dynamic microenvironment for stem cell niche. Biochim. Biophys. Acta 1840, 2506\u20132519 (2014).","journal-title":"Biochim. Biophys. Acta"},{"key":"1055_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-5803-1","volume":"19","author":"M Amrutkar","year":"2019","unstructured":"Amrutkar, M., Aasrum, M., Verbeke, C. S. & Gladhaug, I. P. Secretion of fibronectin by human pancreatic stellate cells promotes chemoresistance to gemcitabine in pancreatic cancer cells. BMC Cancer 19, 596 (2019).","journal-title":"BMC Cancer"},{"key":"1055_CR39","doi-asserted-by":"publisher","first-page":"4266","DOI":"10.1158\/1078-0432.CCR-11-3114","volume":"18","author":"C Feig","year":"2012","unstructured":"Feig, C. et al. The pancreas cancer microenvironment. Clin. Cancer Res. 18, 4266\u20134276 (2012).","journal-title":"Clin. Cancer Res."},{"key":"1055_CR40","doi-asserted-by":"publisher","first-page":"6945046","DOI":"10.1155\/2021\/6945046","volume":"2021","author":"X Liu","year":"2021","unstructured":"Liu, X., Zhou, L., Chen, Y., Jiang, X. & Jiang, J. CircRNF13 promotes the malignant progression of pancreatic cancer through targeting miR-139-5p\/IGF1R axis. J. Oncol. 2021, 6945046 (2021).","journal-title":"J. Oncol."},{"key":"1055_CR41","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1007\/s12033-022-00465-5","volume":"64","author":"B Bao","year":"2022","unstructured":"Bao, B., Yu, X. & Zheng, W. MiR-139-5p targeting CCNB1 modulates proliferation, migration, invasion and cell cycle in lung adenocarcinoma. Mol. Biotechnol. 64, 852\u2013860 (2022).","journal-title":"Mol. Biotechnol."},{"key":"1055_CR42","doi-asserted-by":"publisher","first-page":"100584","DOI":"10.1016\/j.aohep.2021.100584","volume":"27","author":"SS Jin","year":"2022","unstructured":"Jin, S. S., Lin, C. J., Lin, X. F., Zheng, J. Z. & Guan, H. Q. Silencing lncRNA NEAT1 reduces nonalcoholic fatty liver fat deposition by regulating the miR-139-5p\/c-Jun\/SREBP-1c pathway. Ann. Hepatol. 27, 100584 (2022).","journal-title":"Ann. Hepatol."},{"key":"1055_CR43","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/ncb2953","volume":"16","author":"L Seguin","year":"2014","unstructured":"Seguin, L. et al. An integrin \u03b23\u2013KRAS\u2013RalB complex drives tumour stemness and resistance to EGFR inhibition. Nat. Cell Biol. 16, 457\u2013468 (2014).","journal-title":"Nat. Cell Biol."},{"key":"1055_CR44","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.devcel.2014.06.005","volume":"30","author":"JS Desgrosellier","year":"2014","unstructured":"Desgrosellier, J. S. et al. Integrin \u03b1v\u03b23 drives slug activation and stemness in the pregnant and neoplastic mammary gland. Dev. Cell 30, 295\u2013308 (2014).","journal-title":"Dev. Cell"},{"key":"1055_CR45","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1038\/nm.2009","volume":"15","author":"JS Desgrosellier","year":"2009","unstructured":"Desgrosellier, J. S. et al. An integrin \u03b1v\u03b23\u2013c-Src oncogenic unit promotes anchorage-independence and tumor progression. Nat. Med. 15, 1163\u20131169 (2009).","journal-title":"Nat. Med."},{"key":"1055_CR46","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1172\/JCI93707","volume":"128","author":"Q Sun","year":"2018","unstructured":"Sun, Q. et al. Proapoptotic PUMA targets stem-like breast cancer cells to suppress metastasis. J. Clin. Investig. 128, 531\u2013544 (2018).","journal-title":"J. Clin. Investig."},{"key":"1055_CR47","doi-asserted-by":"publisher","first-page":"17703","DOI":"10.1016\/S0021-9258(18)45436-1","volume":"262","author":"DA Cheresh","year":"1987","unstructured":"Cheresh, D. A. & Spiro, R. C. Biosynthetic and functional properties of an Arg-Gly-Asp-directed receptor involved in human melanoma cell attachment to vitronectin, fibrinogen, and von Willebrand factor. J. Biol. Chem. 262, 17703\u201317711 (1987).","journal-title":"J. Biol. Chem."},{"key":"1055_CR48","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jim.2009.06.008","volume":"347","author":"Y Hu","year":"2009","unstructured":"Hu, Y. & Smyth, G. K. ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J. Immunol. Methods 347, 70\u201378 (2009).","journal-title":"J. Immunol. Methods"},{"key":"1055_CR49","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1093\/bioinformatics\/bty852","volume":"35","author":"S Xie","year":"2019","unstructured":"Xie, S. et al. sRNAPrimerDB: comprehensive primer design and search web service for small non-coding RNAs. Bioinformatics 35, 1566\u20131572 (2019).","journal-title":"Bioinformatics"},{"key":"1055_CR50","first-page":"e55051","volume":"119","author":"AL Hellewell","year":"2017","unstructured":"Hellewell, A. L., Rosini, S. & Adams, J. C. A rapid, scalable method for the isolation, functional study, and analysis of cell-derived extracellular matrix. J. Vis. Exp. 119, e55051 (2017).","journal-title":"J. Vis. Exp."},{"key":"1055_CR51","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1158\/2159-8290.CD-17-0539","volume":"7","author":"L Seguin","year":"2017","unstructured":"Seguin, L. et al. Galectin-3, a druggable vulnerability for KRAS-addicted cancers. Cancer Discov. 7, 1464\u20131479 (2017).","journal-title":"Cancer Discov."},{"key":"1055_CR52","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.ccell.2017.10.016","volume":"32","author":"E Cosset","year":"2017","unstructured":"Cosset, E. et al. Glut3 Addiction Is a Druggable Vulnerability for a Molecularly Defined Subpopulation of Glioblastoma. Cancer Cell 32, 856\u2013868.e5 (2017).","journal-title":"Cancer Cell"}],"container-title":["Nature Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41556-022-01055-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41556-022-01055-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41556-022-01055-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T17:06:22Z","timestamp":1673888782000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41556-022-01055-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,16]]},"references-count":52,"alternative-id":["1055"],"URL":"https:\/\/doi.org\/10.1038\/s41556-022-01055-y","relation":{},"ISSN":["1465-7392","1476-4679"],"issn-type":[{"value":"1465-7392","type":"print"},{"value":"1476-4679","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,16]]},"assertion":[{"value":"14 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}